发明名称 Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
摘要 Described herein are methods of treating a mammal in need of treatment for non-histaminic pruritus by administering to the mammal in need thereof a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof, thereby reducing the desire to scratch in the mammal. Non-histaminergic types of pruritus are resistant to treatment with selective histamine H-1-, H-2- and H-4-receptor inhibitors. In certain aspects, the non-histaminergic pruritus is associated with diabetes.
申请公布号 US9439895(B2) 申请公布日期 2016.09.13
申请号 US201615134807 申请日期 2016.04.21
申请人 BRIDGE PHARMA, INC. 发明人 Aberg A.K. Gunnar;Ciofalo Vincent B.
分类号 A01N43/40;A61K31/445;A61K31/4535;A61K9/00 主分类号 A01N43/40
代理机构 Cantor Colburn LLP 代理人 Cantor Colburn LLP
主权项 1. A method of treating a mammal in need of treatment for non-histaminic pruritus, comprising orally administering to the mammal in need thereof a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof, thereby reducing the desire to scratch in the mammal, wherein the non-histaminergic pruritus is resistant to treatment with selective histamine H-1-receptor inhibitors, histamine H-2-receptor inhibitors and histamine H-4-receptor inhibitors, and wherein the mammal is suffering from diabetes mellitus.
地址 Sarasota FL US